Remedent(REMI)
$0.010.00 (0.00%)
REMI
Remedent financials statements
$0.01
At close:0.00 (0.00%)
Remedent (REMI) Ratios
13 Followers
Remedent Ratios
REMI's free cash flow for Q4 2024 was $-92.50K. For the 2024 fiscal year, REMI's free cash flow was increased by $0.00 and operating cash flow was $-92.50K. See a summary of the company’s cash flow.
| Ratios | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.33 | 0.32 | 0.38 | 0.21 | 0.24 |
| Quick Ratio | 0.30 | 0.29 | 0.34 | 0.17 | 0.20 |
| Cash Ratio | 0.01 | 0.04 | 0.06 | 0.03 | 0.04 |
| Solvency Ratio | -0.08 | -0.52 | -0.08 | -0.05 | -0.40 |
| Operating Cash Flow Ratio | -0.04 | -0.02 | -0.06 | 0.00 | 0.04 |
| Short-Term Operating Cash Flow Coverage | -8.43 | 0.00 | 0.00 | 0.32 | -0.20 |
| Net Current Asset Value | $ -2.03M | $ -1.93M | $ -1.68M | $ -2.18M | $ -2.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.40 | 2.16 | 1.69 | 1.66 | 1.65 |
| Debt Service Coverage Ratio | -14.98 | -353.58 | -23.90 | -11.35 | 1.58 |
| Interest Coverage Ratio | 0.00 | -68.50 | 42.87 | -8.58 | -34.05 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | -0.14 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.13 | 0.07 | 1.13 | 0.71 | 0.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.17% | 58.53% | 74.38% | 56.18% | 69.73% |
| EBIT Margin | -23.82% | -170.00% | -12.94% | -13.37% | -78.71% |
| EBITDA Margin | -21.82% | -167.08% | -10.91% | -9.87% | -72.02% |
| Operating Profit Margin | -12.46% | -32.76% | 22.55% | -3.13% | -45.06% |
| Pretax Profit Margin | -23.82% | -170.48% | -13.46% | -13.73% | -80.04% |
| Net Profit Margin | -27.83% | -173.05% | -18.27% | -15.84% | -80.26% |
| Continuous Operations Profit Margin | -25.50% | -172.53% | -15.12% | -14.01% | -80.26% |
| Net Income Per EBT | 116.84% | 101.51% | 135.71% | 115.32% | 100.27% |
| EBT Per EBIT | 191.14% | 520.31% | -59.69% | 438.96% | 177.63% |
| Return on Assets (ROA) | -5.00% | -26.75% | -3.70% | -2.27% | -11.38% |
| Return on Equity (ROE) | -12.02% | -57.66% | -6.25% | -3.76% | -18.79% |
| Return on Capital Employed (ROCE) | -5.02% | -10.35% | 7.47% | -0.73% | -10.37% |
| Return on Invested Capital (ROIC) | -4.99% | -10.35% | 7.47% | -0.73% | -11.27% |
| Return on Tangible Assets | -5.00% | -26.85% | -3.72% | -2.29% | -11.38% |
| Earnings Yield | -21.00% | -43.97% | -7.57% | -4.29% | -23.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.14 | 1.20 | 1.89 | 2.67 | 3.23 |
| Payables Turnover | 0.16 | 0.26 | 0.17 | 0.20 | 0.14 |
| Inventory Turnover | 4.17 | 3.86 | 3.82 | 4.41 | 3.55 |
| Fixed Asset Turnover | 47.99 | 21.03 | 20.59 | 15.19 | 15.87 |
| Asset Turnover | 0.18 | 0.15 | 0.20 | 0.14 | 0.14 |
| Working Capital Turnover Ratio | -0.50 | -0.48 | -0.73 | -0.47 | -0.54 |
| Cash Conversion Cycle | -1823.05 | -1027.13 | -1913.13 | -1592.38 | -2383.51 |
| Days of Sales Outstanding | 321.58 | 305.15 | 193.31 | 136.85 | 112.93 |
| Days of Inventory Outstanding | 87.57 | 94.54 | 95.63 | 82.77 | 102.89 |
| Days of Payables Outstanding | 2232.20 | 1426.82 | 2202.07 | 1811.99 | 2599.34 |
| Operating Cycle | 409.15 | 399.69 | 288.94 | 219.62 | 215.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.00 | -0.01 | 0.00 | 0.01 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | 0.00 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | -43504.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -43504.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -8.43 | 0.00 | 0.00 | 0.32 | 18.62 |
| Operating Cash Flow to Sales Ratio | -0.13 | -0.06 | -0.12 | 0.00 | 0.10 |
| Free Cash Flow Yield | -9.99% | -1.56% | -4.97% | 0.05% | 2.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.76 | -2.27 | -13.22 | -23.29 | -4.21 |
| Price-to-Sales (P/S) Ratio | 1.32 | 3.94 | 2.41 | 3.69 | 3.38 |
| Price-to-Book (P/B) Ratio | 0.57 | 1.31 | 0.83 | 0.88 | 0.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.01 | -64.05 | -20.12 | 2207.57 | 35.44 |
| Price-to-Operating Cash Flow Ratio | -10.01 | -64.05 | -20.12 | 2207.57 | 35.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | -0.00 | -0.23 | 0.29 | 0.03 |
| Enterprise Value Multiple | -5.94 | -2.28 | -21.00 | -36.64 | -4.55 |
| Enterprise Value | 1.28M | 3.29M | 3.23M | 3.73M | 3.49M |
| EV to EBITDA | -5.94 | -2.28 | -21.00 | -36.64 | -4.55 |
| EV to Sales | 1.30 | 3.81 | 2.29 | 3.62 | 3.28 |
| EV to Free Cash Flow | -9.80 | -62.07 | -19.09 | 2165.52 | 34.37 |
| EV to Operating Cash Flow | -9.80 | -62.07 | -19.09 | 2165.52 | 34.37 |
| Tangible Book Value Per Share | 0.12 | 0.14 | 0.21 | 0.22 | 0.23 |
| Shareholders’ Equity Per Share | 0.11 | 0.13 | 0.21 | 0.22 | 0.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.07 | -0.01 | -0.12 | -0.02 | -0.00 |
| Revenue Per Share | 0.05 | 0.04 | 0.07 | 0.05 | 0.05 |
| Net Income Per Share | -0.01 | -0.07 | -0.01 | -0.01 | -0.04 |
| Tax Burden | 1.17 | 1.02 | 1.36 | 1.15 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.04 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.70 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.48 | 0.16 | -1.16 | 0.16 | -0.12 |
Currency in USD

